CtrlK
NeuroSense Therapeutics Ltd.
NRSN35
$1.010.00%$0.00
NASDAQ - As of Apr 23, 5:52 AM EDT Market Closed
Penny Stock
NRSN35
$1.01
0.00%Performance History
arrow_drop_down24.62%
(-$0.33 )
| Key Stats | |
|---|---|
| Open | $1.01 |
| Prev. Close | $1.01 |
| EPS | -0.76 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $24.62M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 1.01 | 1.01 |
| 52 Week Range | 0.40 | 2.33 |
| Ratios | |
|---|---|
| P/B Ratio | 4.15 |
| Revenue | - |
| Operating M. % | 0.00% |
| Earnings | $0.00 |
| Earnings Growth % | 8.59% |
| EBITDA Margin % | - |
| ROE % | -494.84% |
| EPS | -0.76 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
About NeuroSense Therapeutics Ltd. (NRSN)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Alon Ben-Noon
- Headquarters
- Herzliya
- Employees
- 14
- Exchange
- NASDAQ
Keep an eye on NeuroSense Therapeutics Ltd.
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is NeuroSense Therapeutics Ltd.'s (NRSN) price per share?
The current price per share for NeuroSense Therapeutics Ltd. (NRSN) is $1.01. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for NeuroSense Therapeutics Ltd. (NRSN)?
For NeuroSense Therapeutics Ltd. (NRSN), the 52-week high is $2.33, which is 130.69% from the current price. The 52-week low is $0.4, the current price is 152.5% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is NeuroSense Therapeutics Ltd. (NRSN) a growth stock?
NeuroSense Therapeutics Ltd. (NRSN) has shown an average price growth of -1.65% over the past three years. It has received a score of 29 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying NeuroSense Therapeutics Ltd. as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is NeuroSense Therapeutics Ltd. (NRSN) stock price performance year to date (YTD)?
As of the latest data, NeuroSense Therapeutics Ltd. (NRSN) has a year-to-date price change of -15.83%. Over the past month, the stock has experienced a price change of -6.48%. Over the last three months, the change has been -7.34%. Over the past six months, the figure is -12.17%.
help
Is NeuroSense Therapeutics Ltd. (NRSN) a profitable company?
NeuroSense Therapeutics Ltd. (NRSN) has a net income of -$11.28M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$12.05M. Furthermore, the EBITDA is -$11.17M.
help
What is the market capitalization of NeuroSense Therapeutics Ltd. (NRSN)?
NeuroSense Therapeutics Ltd. (NRSN) has a market capitalization of $24.62M. The average daily trading volume is 0, indicating the stock's liquidity and investor engagement.